Exosomes and cancer: a newly described pathway of immune suppression.
about
Exosomes for Immunoregulation and Therapeutic Intervention in CancerFocus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane VesiclesNovel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talkExosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesionsUpdate on the challenges and recent advances in cancer immunotherapyExosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS.Coordinated regulation of myeloid cells by tumoursExosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial diseaseTumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and TherapyExtracellular vesicles: exosomes, microvesicles, and friendsExosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells.Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functionsPost-transcriptional processing of genetic information and its relation to cancer.Differential fates of biomolecules delivered to target cells via extracellular vesicles.Comparison of ultracentrifugation and density gradient separation methods for isolating Tca8113 human tongue cancer cell line-derived exosomes.Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancerModeling putative therapeutic implications of exosome exchange between tumor and immune cells.Genetics, genomics, and evolutionary biology of NKG2D ligands.Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cellsExosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization.Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progressionInteractions between cancer cells and normal cells via miRNAs in extracellular vesicles.Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based MethodIncreasing vaccine potency through exosome antigen targeting.DNA in serum extracellular vesicles is stable under different storage conditions.Exosomal transfer of functional small RNAs mediates cancer-stroma communication in human endometrium.Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.Heparanase regulates secretion, composition, and function of tumor cell-derived exosomesSmall RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.Molecular characterization of S. japonicum exosome-like vesicles reveals their regulatory roles in parasite-host interactions.Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles.Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery SystemsBiochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophagesThe Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell CarcinomaTLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
P2860
Q26744193-5D1C9C9B-483D-4CCD-A0BC-2AACC45DC31BQ26767270-8FCC7337-465C-4B7E-BCFB-C232E74A6C5CQ26778352-A3783E66-E860-4AC1-8543-79D3F1395033Q27008452-579AD6E4-CEF0-41BC-9FD7-7C44FA45C14EQ27014693-7A113C19-FF1B-45DD-A763-1F88D7F187E1Q27309031-6ADB1870-BAAD-4CDC-85A7-99461932D88BQ28395157-49F5FBCE-1828-4C45-90F7-9BEE4B4EAEB1Q28739536-788DB09A-3991-4D36-862B-715BAEA98E09Q28817133-1F55AA0E-AFB5-4C2A-BC32-5173B5F67CC6Q29618137-B182C7E6-024F-480F-B797-5BB3990EDE3EQ33746697-1386B94F-6F6B-4D13-8343-836F68058AE5Q33791173-BFE2D845-26CE-4CCA-91C2-931D070C2E50Q33881478-9948CE9B-953A-4D80-BD4C-7846F244DDD1Q34043252-C1354787-7CE9-45D5-AFB6-10B4599B87BFQ34141488-5E06C4DC-A139-43F5-B344-BCD677BBF0A2Q34221714-663BED84-C68F-42CC-98B7-7CC60F930D17Q34384632-7D7E95AF-B9DA-4EB4-9EFD-505FFD7BDC3EQ34407541-A035280A-FFE0-4D58-8201-E82F1E4A1F53Q34489980-DD7E8369-A531-4183-86B1-6C42C83FC0CDQ34874654-A2916EBD-185E-423D-91B3-772F0475BC89Q34909956-236F865B-CAC6-4702-86CA-EDECD849A4B7Q34999444-B51370FE-A614-496A-8407-9F1C9E265A09Q35546267-122C6BE4-BCA5-4A22-BCB0-7E6F47805DBAQ35608487-6E675212-3169-4CCA-AFE4-1135C8168397Q35758580-964230DE-6A4E-4250-85B0-A67A3794B9D7Q35955224-9FAD395B-4511-4098-9E14-2345A3B2ABC5Q36143293-95D6F75A-756A-4462-97D6-D6189B106657Q36528364-D1657CA0-0563-4F7A-B5DA-AA93704664A5Q36530717-04A581E7-7153-43B1-8A8E-85B874E09D22Q36542190-B3AA0A55-5E19-4EB4-8847-7F842ED92BF2Q36695084-8DE67604-8BE3-4E9E-A78D-F8FBAB6235D6Q36742116-5AED64D0-A53A-42D4-B0B1-85B3BDD27763Q36838683-C3E01EE2-61A4-4CF1-A395-3362EEEF967FQ36897972-0B20CCAD-31E8-4795-BAF5-DD8FDE88C09DQ37073022-A6EA6BCB-0214-4CF2-A0AE-A8456F3F7269Q37087862-2193B972-7B84-48C8-9FCC-1A8785D74AEAQ37117425-86A02156-1DA7-4179-B240-5E918CC706E3Q37205286-3125CB23-77FF-4ADE-B406-9531F29AE821Q37427920-E1351D73-B41A-46B1-9F96-28516D42A83DQ37706972-6ADBA9DC-16A7-48E1-B92E-44AA2CB9FE5B
P2860
Exosomes and cancer: a newly described pathway of immune suppression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Exosomes and cancer: a newly described pathway of immune suppression.
@ast
Exosomes and cancer: a newly described pathway of immune suppression.
@en
type
label
Exosomes and cancer: a newly described pathway of immune suppression.
@ast
Exosomes and cancer: a newly described pathway of immune suppression.
@en
prefLabel
Exosomes and cancer: a newly described pathway of immune suppression.
@ast
Exosomes and cancer: a newly described pathway of immune suppression.
@en
P2860
P1476
Exosomes and cancer: a newly described pathway of immune suppression.
@en
P2093
Huang-Ge Zhang
William E Grizzle
P2860
P304
P356
10.1158/1078-0432.CCR-10-1489
P407
P577
2011-01-11T00:00:00Z